As of 2024-12-12, the Fair Value of Myriad Genetics Inc (MYGN) is -6.37 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 14.51 USD, the upside of Myriad Genetics Inc is -143.91%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -199.50 | -53.10 | -27.20 | -112.00 | -263.30 | -131.02 |
| YoY growth | -4,436.96% | 73.38% | 48.78% | -311.76% | -135.09% | -952.33% |
| Market Cap (mil) | 1,320.99 |
| P/E | |
| Forward P/E |
| EPS | -1.27 |
| Avg earnings growth rate | -952.33% |
| TTM earnings | -116.00 |